Literature DB >> 8613967

Tolerance of hypothalamic beta-endorphin neurons to mu-opioid receptor activation after chronic morphine.

G Zhang1, A H Lagrange, O K Rønnekleiv, M J Kelly.   

Abstract

The mu-opioid receptor is an autoreceptor on hypothalamic beta-endorphin neurons that when activated inhibits cell firing via increasing an inwardly rectifying potassium conductance. The membrane hyperpolarization to DAMGO ([D-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin) in beta-endorphin and other arcuate (ARC) neurons was investigated in hypothalamic slices from control and morphine-treated, ovariectomized guinea pigs. Chronic morphine treatment caused both a decreased potency (EC50 220 +/- 10 nM vs. 64 +/- 3 nM in controls) and a decreased efficacy (Vmax: -7.1 +/- 1.1 mV vs. -10.7 +/- 0.6 mV in controls) of DAMGO in a population of ARC neurons including beta-endorphin neurons. In another population of ARC neurons from morphine-treated animals, DAMGO was less potent (EC50: 110 +/- 4 nm) than in controls (EC50: 64 +/- 3nM), but there was not a significant change in the efficacy of DAMGO. Twenty percent of ARC neurons did not exhibit any signs of tolerance. The density of mu-opioid receptors labeled with the antagonist radioligand [3H]diprenorphine was found to be significantly decreased in the ARC and surrounding mediobasal hypothalamus after morphine treatment (Bmax: 217 +/- 9 vs. 276 +/- 16 fmol/mg protein in controls), which is consistent with the altered response in beta-endorphin neurons. In summary, chronic morphine treatment decreases mu-opioid receptor density and the functional coupling of mu-opioid receptors to K+ channels in ARC neurons. This expression of morphine tolerance by beta-endorphin (ARC) neurons may serve as a homeostatic mechanism to maintain opioid control of a variety of systems ranging from reproduction to motivation and reward.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613967

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Understanding endorphins and their importance in pain management.

Authors:  Adam S Sprouse-Blum; Greg Smith; Daniel Sugai; F Don Parsa
Journal:  Hawaii Med J       Date:  2010-03

2.  β-Endorphin neuronal transplantation into the hypothalamus alters anxiety-like behaviors in prenatal alcohol-exposed rats and alcohol-non-preferring and alcohol-preferring rats.

Authors:  Ryan W Logan; Olivia Wynne; George Maglakelidze; Changqing Zhang; Stephanie O'Connell; Nadka I Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

Review 3.  Avoiding Opioids and Their Harmful Side Effects in the Postoperative Patient: Exogenous Opioids, Endogenous Endorphins, Wellness, Mood, and Their Relation to Postoperative Pain.

Authors:  Bradley C Stephan; Fereydoun D Parsa
Journal:  Hawaii J Med Public Health       Date:  2016-03

4.  Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations.

Authors:  M A Kelly; M Rubinstein; T J Phillips; C N Lessov; S Burkhart-Kasch; G Zhang; J R Bunzow; Y Fang; G A Gerhardt; D K Grandy; M J Low
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

5.  Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.

Authors:  Y Wang; R Xu; T Sasaoka; S Tonegawa; M P Kung; E B Sankoorikal
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

6.  Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.

Authors:  L J Sim-Selley; K L Scoggins; M P Cassidy; L A Smith; W L Dewey; F L Smith; D E Selley
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.